|
Mark Miller will discuss the public health perspective on RSV. With extensive research experience at the US National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), UN Agencies and Yale University School of Medicine, he is skilled in the field of public and global health, health economics, and vaccine development regarding rapidly transmissible viruses, such as RSV. |
Guest Speaker: 
Mark Miller, MD
Guest Researcher, National Institutes of Health (NIH) - Bethesda, Maryland, US |
Host: 
Prof Harish Nair
Chair of Paediatric Infectious Diseases and Global Health, University of Edinburgh - Edinburgh, Scotland, UK |
|
|
|
|
YOU CAN HELP
How familiar are you with RSV and possible vaccinations? You can help us by filling out the questionnaire in this link. Though your answers remain completely anonymous, they offer us insight into the general opinion towards RSV vaccination. It will only take about 10 minutes! Our target groups are pregnant women, women who want to become pregnant, parents of infants and/or children, older adults over the age of 60. ABOUT PROMISE
The aim of PROMISE is to significantly advance our understanding of RSV to aid in the design of public health strategies as well as the development and use of vaccines and therapeutics in both children and older people. It builds on the work of IMI’s RESCEU project, which has delivered significant insights and resources on RSV. |
|
We are proud to announce that the registration and abstract submission for our upcoming conference RSVVW'23 - A Global Conference On Novel RSV Preventive and Therapeutic Interventions has opened as of June 15th!
Register now to learn and share knowledge on current research, and to connect worldwide the leading researchers, scientists, physicians, industry, academic scientists, scholars, decision-makers, and representatives from regulatory, global health, and governmental organisations. On our website, you can find: |
- January 2022 -
Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study |
- August 2021 -
Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study |
- January 2022 -
Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study |
RSV VACCINATION STUDIES
There are ongoing phase 3 maternal and adult vaccination studies, respectively. Phase 3 maternal vaccination study aims to analyse the efficacy of RSVpreF vaccine in infants born to women vaccinated during pregnancy. Phase 3 adult vaccination study aims to analyse the efficacy, immunogenicity and safety of the RSVpreF vaccine candidate in 30,000 subjects. |
RSV EPIDEMIOLOGY STUDIES
INFORM and RSV GOLD are ongoing studies to gain insight into RSV Epidemiology. INFORM aims to investigate the worldwide molecular diversity of RSV isolates collected from children less than 5 years of age. RSV GOLD aims to fill gaps in global clinical data on RSV, and hence create a global online database of RSV morality in young children. |
MORE STUDIES
PROMISE is a project that works to develop a robust surveillance network on RSV disease, with the goal of strengthening epidemiological and virological surveillance in EUROPE. BRICE is an observational study of children under the age of two who have been hospitalized with RSV, with the aim of incidence rate of hospitalizations and burdens associated with RSV. |
